The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Perioperative versus adjuvant therapy in resectable pancreas cancer.
 
Tianyi Wang
No Relationships to Disclose
 
Jamie Mills
No Relationships to Disclose
 
Brandon Ellsworth
No Relationships to Disclose
 
Brian Griffith
No Relationships to Disclose
 
Valerie Gunchick
Consulting or Advisory Role - Cornerstone Pharmaceuticals
 
Thomas Enzler
Research Funding - Abbvie; Agenus; Amgen; Arcus Biosciences; AstraZeneca; AstraZeneca; BioMed Valley Discoveries (Inst); CanBas; ECOG-ACRIN; Exelixis; Hoosier Cancer Research Network; NeoImmuneTech; Taiho Oncology; Tvardi Therapeutics
 
Oxana Crysler
Research Funding - ACCRU (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); MedImmune (Inst)
 
Kyle Cuneo
Employment - University of Michigan
Research Funding - NIH; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - Combined Radiation Acoustics and Ultrasound for Radiotherapy Guidance and Cancer Targeting 5/1/2019
 
Hari Nathan
Research Funding - Blue Cross Blue Shield of Michigan (Inst)
 
Theodore Lawrence
No Relationships to Disclose
 
Mark Zalupski
Research Funding - AstraZeneca/MedImmune; BioMed Valley Discoveries; Seagen
 
Clifford Cho
No Relationships to Disclose
 
Vaibhav Sahai
Consulting or Advisory Role - AstraZeneca; Autem Medical; Delcath Systems; Elevar Therapeutics; Histosonics; Incyte; Ipsen; Jazz Pharmaceuticals; Lynx Group; Rafael Pharmaceuticals; SERVIER; Taiho Oncology
Research Funding - Actuate Therapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Elicio Therapeutics (Inst); Esanik (Inst); Exelixis (Inst); FibroGen (Inst); Ipsen (Inst); MedImmune (Inst); Pancreatic Cancer Action Network (Inst); Rafael Pharmaceuticals (Inst); Relay Therapeutics (Inst); Relay Therapeutics (Inst); Repare Therapeutics (Inst); SERVIER (Inst); Syros Pharmaceuticals (Inst); TransThera Biosciences (Inst)
Travel, Accommodations, Expenses - ASCO; Lynx Group
Other Relationship - Rafael Pharmaceuticals (Inst)
 
Filip Bednar
No Relationships to Disclose